CLINICAL TRIALS PROFILE FOR CYCLOPENTOLATE HYDROCHLORIDE
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Cyclopentolate Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00348166 ↗ | Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children? | Withdrawn | KK Women's and Children's Hospital | Phase 1 | 2005-12-01 | The purpose of this study is to find out if undercorrection of myopia slow down the progression of myopia in kindergarten children. |
| NCT01170130 ↗ | Lidocaine Usage for Pupil Dilatation (Mydriasis) | Completed | Carmel Medical Center | N/A | 2009-12-01 | The purpose of this study is to determine if the mydriatic effect of intracameral lidocaine 1% is as effective as topical cyclopentolate 1% and phenylephrine 10% for achieving effective mydriasis during phacoemulsification surgery. |
| NCT02177539 ↗ | A New More Efficient Cycloplegia Scheme | Unknown status | Pontificia Universidad Catolica de Chile | Phase 4 | 2014-05-01 | The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme) |
| NCT02309385 ↗ | Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis | Completed | National Eye Institute (NEI) | Phase 1/Phase 2 | 2014-10-01 | The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis. |
| NCT02309385 ↗ | Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis | Completed | Aciont Inc | Phase 1/Phase 2 | 2014-10-01 | The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis. |
| NCT02895035 ↗ | Comparison of Epinephrine and Phenylephrine/Ketorolac With Regards to Pupil Size | Terminated | Milton S. Hershey Medical Center | Phase 4 | 2016-09-01 | The objective of this study is to compare the maintenance of intraoperative mydriasis during cataract surgery between two drugs: epinephrine, which has routinely been used for decades, and Omidria, a newly FDA approved combination drug of phenylephrine and ketorolac. Patients undergoing cataract surgery that are enrolled in the trial will randomly receive one of the drugs in one eye, and the other eye will receive the drug during the subsequent cataract surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Cyclopentolate Hydrochloride
Condition Name
Clinical Trial Locations for Cyclopentolate Hydrochloride
Trials by Country
Clinical Trial Progress for Cyclopentolate Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Cyclopentolate Hydrochloride
Sponsor Name
